Samsung Biologics bids $1.8 billion for PolyPeptide
The South Korean drug manufacturer is moving into peptide medicines as demand rises for GLP-1 obesity and diabetes treatments.
Section
The South Korean drug manufacturer is moving into peptide medicines as demand rises for GLP-1 obesity and diabetes treatments.
The budget airline said profit dropped 34% as unhedged fuel costs jumped and lower fares reflected later bookings tied to the Midd...
The optical transceivers company is testing investor demand as Hong Kong’s listing market rebounds, according to Bloomberg, LSEG a...
The U.S. carried out a ninth straight night of strikes on Iran while casualties rose and oil traders watched slowing traffic throu...
Kelly Ortberg told CNBC Boeing needs a couple more years to strengthen its finances before it can launch a new commercial aircraft...
CFO Wendell Huang told CNBC the chipmaker is adding U.S. capacity as AI demand pushes capital spending higher.
Zoe De La Paz now earns $19.25 an hour repairing park uniforms, using a seasonal job as a step toward costuming work in New York.
Epstein survivors said Todd Blanche was evasive in a DOJ meeting tied to his attorney general confirmation fight, while Sen. Thom...
DOJ and DHS denied a report that the FBI will stop investigating assault claims involving ICE agents after fatal shootings.
Universal’s Christopher Nolan film drew premium-screen crowds, giving the director his biggest global debut, according to Rentrak...
Eli Lilly’s planned AtaiBeckley acquisition signals rising pharma interest in psychedelic-based mental health drugs, despite regul...
Psychotherapist Amy Morin says couples can replace routine workday check-ins with questions that build connection, gratitude and t...